61
Improving Stroke Prevention in Patients With Atrial Fibrillation

Improving Stroke Prevention in Patients With Atrial Fibrillation

Embed Size (px)

Citation preview

Page 1: Improving Stroke Prevention in Patients With Atrial Fibrillation

Improving Stroke Prevention in Patients With Atrial Fibrillation

Page 2: Improving Stroke Prevention in Patients With Atrial Fibrillation

Acknowledgement

Page 3: Improving Stroke Prevention in Patients With Atrial Fibrillation

Disclosures

Page 4: Improving Stroke Prevention in Patients With Atrial Fibrillation

Disclosures (cont.)

• This presentation will not include any non-FDA approved or investigational uses of products or medical devices.

Page 5: Improving Stroke Prevention in Patients With Atrial Fibrillation

Learning Objectives

Page 6: Improving Stroke Prevention in Patients With Atrial Fibrillation

Atrial Fibrillation (AF): Incidence and Consequences

Page 7: Improving Stroke Prevention in Patients With Atrial Fibrillation

Projected Number of Persons With AF in the US: 2000 to 2050

Page 8: Improving Stroke Prevention in Patients With Atrial Fibrillation

AF and Stroke

Page 9: Improving Stroke Prevention in Patients With Atrial Fibrillation

Greater Risk of Death and Recurrence With AF Strokes

Page 10: Improving Stroke Prevention in Patients With Atrial Fibrillation

Disability vs Age Group in Those With Acute Ischemic Stroke (AIS) vs AF-AIS

Page 11: Improving Stroke Prevention in Patients With Atrial Fibrillation

Anticoagulation: Assessing Benefits and Risks

Page 12: Improving Stroke Prevention in Patients With Atrial Fibrillation

Question

Page 13: Improving Stroke Prevention in Patients With Atrial Fibrillation

Case 1

Page 14: Improving Stroke Prevention in Patients With Atrial Fibrillation

CHADS2 Index: A Validated Classification Scheme/Tool for Stroke Risk

Page 15: Improving Stroke Prevention in Patients With Atrial Fibrillation
Page 16: Improving Stroke Prevention in Patients With Atrial Fibrillation

Weakness of CHADS2

Page 17: Improving Stroke Prevention in Patients With Atrial Fibrillation

The CHA2DS2-VASc Index

Page 18: Improving Stroke Prevention in Patients With Atrial Fibrillation

CHA2DS2-VASc vs CHADS2: Which to Use?

Page 19: Improving Stroke Prevention in Patients With Atrial Fibrillation

Case 2

Page 20: Improving Stroke Prevention in Patients With Atrial Fibrillation

ACC/AHA/ESC Guidelines

Page 21: Improving Stroke Prevention in Patients With Atrial Fibrillation

Risk Stratification and Anticoagulation

Page 22: Improving Stroke Prevention in Patients With Atrial Fibrillation

Underuse of Anticoagulants in AF

Page 23: Improving Stroke Prevention in Patients With Atrial Fibrillation

Barriers to Anticoagulant Use

Page 24: Improving Stroke Prevention in Patients With Atrial Fibrillation

Barriers to Anticoagulation?

Page 25: Improving Stroke Prevention in Patients With Atrial Fibrillation

Bleeding Risk

Page 26: Improving Stroke Prevention in Patients With Atrial Fibrillation

Bleeding Risk: The Reality

Page 27: Improving Stroke Prevention in Patients With Atrial Fibrillation

Anticoagulation in Patients at Risk of Falls: “Physicians’ Fears Are Often Unfounded”

Page 28: Improving Stroke Prevention in Patients With Atrial Fibrillation

Assessing Bleeding Risk: HAS-BLED

Page 29: Improving Stroke Prevention in Patients With Atrial Fibrillation

Reducing Bleeding Risk

Page 30: Improving Stroke Prevention in Patients With Atrial Fibrillation

Anticoagulation Decision Support Worksheet

Page 31: Improving Stroke Prevention in Patients With Atrial Fibrillation

Anticoagulation Decision Support Worksheet (cont.)

Page 32: Improving Stroke Prevention in Patients With Atrial Fibrillation

The Patient: Decision Making and Education

Page 33: Improving Stroke Prevention in Patients With Atrial Fibrillation

Patient Preferences

Page 34: Improving Stroke Prevention in Patients With Atrial Fibrillation

Patient vs Physician Perspectives on Anticoagulation

Page 35: Improving Stroke Prevention in Patients With Atrial Fibrillation

Explaining Risk to Patients: Numerous Tools Available

Page 36: Improving Stroke Prevention in Patients With Atrial Fibrillation

Patient Knowledge About Warfarin

Page 37: Improving Stroke Prevention in Patients With Atrial Fibrillation

Patient Adherence to Warfarin

Page 38: Improving Stroke Prevention in Patients With Atrial Fibrillation

Risk Factors for Warfarin Nonadherence

Page 39: Improving Stroke Prevention in Patients With Atrial Fibrillation

Improving Patient Adherence to Anticoagulants

Page 40: Improving Stroke Prevention in Patients With Atrial Fibrillation

Which Antithrombotic Therapy?

Page 41: Improving Stroke Prevention in Patients With Atrial Fibrillation

Generic/Trade Name Guide for Drugs Mentioned in Presentation

Page 42: Improving Stroke Prevention in Patients With Atrial Fibrillation

Features of Available Anticoagulants

Page 43: Improving Stroke Prevention in Patients With Atrial Fibrillation

Warfarin and Novel Anticoagulant Mechanisms of Action

Page 44: Improving Stroke Prevention in Patients With Atrial Fibrillation

Choosing an Anticoagulant

Page 45: Improving Stroke Prevention in Patients With Atrial Fibrillation

Question Check

Page 46: Improving Stroke Prevention in Patients With Atrial Fibrillation

Clopidogrel and/or Aspirin?

Page 47: Improving Stroke Prevention in Patients With Atrial Fibrillation

ACC/AHA/ESC Guidelines: Warfarin vs Aspirin

Page 48: Improving Stroke Prevention in Patients With Atrial Fibrillation

Warfarin: The Gold Standard

Page 49: Improving Stroke Prevention in Patients With Atrial Fibrillation

Currently Available Oral Anticoagulants

Page 50: Improving Stroke Prevention in Patients With Atrial Fibrillation

Clinical Trial Data

Page 51: Improving Stroke Prevention in Patients With Atrial Fibrillation

Limitations/Concerns With Available Anticoagulants

Page 52: Improving Stroke Prevention in Patients With Atrial Fibrillation

Visit TEAManticoag.com for a Medication Chart (Keyword: chart)

Page 53: Improving Stroke Prevention in Patients With Atrial Fibrillation

ACC/AHA/ESC Guidelines: Managing Through Medical Procedures

to Prevent Thrombosis

Page 54: Improving Stroke Prevention in Patients With Atrial Fibrillation

Drug-Specific Guidelines for Managing Through Medical Procedures

Page 55: Improving Stroke Prevention in Patients With Atrial Fibrillation

When to Switch From Warfarin

Page 56: Improving Stroke Prevention in Patients With Atrial Fibrillation

Remain With Warfarin if …

Page 57: Improving Stroke Prevention in Patients With Atrial Fibrillation

Switching From Warfarin: How?

Page 58: Improving Stroke Prevention in Patients With Atrial Fibrillation

Visit TEAManticoag.com for Tools, Handouts, Calculators, and More

Page 59: Improving Stroke Prevention in Patients With Atrial Fibrillation

Periprocedural Anticoagulation Algorithm on TEAManticoag.com (Keyword: periprocedural)

Page 60: Improving Stroke Prevention in Patients With Atrial Fibrillation

Decision Tool to Use With Patients on TEAManticoag.com (Keyword: decision)

Page 61: Improving Stroke Prevention in Patients With Atrial Fibrillation

TEAM-A Town Hall on TEAManticoag.com